Researchers surveyed 719 pharmacists at large and small hospitals
across the country in 2018. Every one of them reported experiencing
at least one drug shortage in the past year, and 69 percent had
dealt with at least 50 shortages in that time.
Most often, pharmacists said they had less than a month of warning
about dwindling supplies before they had to manage an active drug
shortage, the study team reports in JAMA Internal Medicine.
Four in five pharmacists said they hoarded scarce medicines. One in
three said the hospital had to ration drugs and deny medicines to at
least some patients who needed them.
"Patients are not commonly told when this occurs," said lead author
Dr. Andrew Hantel of the University of Chicago.
"These are issues that directly impact patients and they should be
aware that they exist and occur throughout the United States,"
Hantel said by email.
One in three pharmacists said their hospital had no valid
administrative mechanism to help them respond to a shortage.
Roughly half the time, individual doctors or treatment teams made
decisions on their own about how to allocate drugs being rationed,
the study also found.
While most of the rest of the rationing decisions were made by
committees, only 5 percent of committees included medical ethicists
to help guide the use of scarce medicines.
Rationing was more common at academic hospitals and their affiliates
than at community hospitals.
Many drugs involved in hospital shortages are injected or infused
medicines for pain relief, treating common health problems like
cancer and heart conditions, and fighting infections.
Presently, 226 medicines are in short supply, according to a running
list kept by the American Society for Hospital Pharmacists. Current
shortages include cancer drugs, vaccines and heart medicines.
[to top of second column] |
The study wasn't designed to look at whether shortages directly
impact patient outcomes. It's also possible that shortages in
hospitals might differ from supply problems for drugs people
commonly take at home, the study authors note. Researchers also
didn't examine the causes of drug shortages.
"Shortages can happen for many reasons, including disruptions in the
supply chain, manufacturers leaving the market and even natural
disasters," said Dr. Aaron Kesselheim, a researcher at Brigham and
Women's Hospital and Harvard Medical School in Boston who wasn't
involved in the study.
"When Hurricane Maria, for example, tragically struck Puerto Rico,
much of the U.S. supply of normal saline was affected because much
of it was manufactured there," Kesselheim said by email.
"Policymakers should take up the question of whether a back-up
system is needed to ensure that basic staples of inpatient
healthcare delivery remain available," Kesselheim added.
"Substitutes may not be available in all cases, and we conducted a
study showing that in the case of a shortage of one product, we
found that manufacturers of substitutes responded by apparently
raising their prices."
Patients are often in the dark, said Stacie Dusetzina, a health
policy researcher at Vanderbilt University School of Medicine in
Nashville, Tennessee, who wasn't involved in the study.
"In cases where there is a clear substitute, then there may be no
impact on patients," Dusetzina said by email. "However, knowing that
you cannot obtain a drug that your doctor wants you to take and that
there are no substitutes available could be highly distressing and
could impact patient health."
SOURCE: https://bit.ly/2CDGPq4 JAMA Internal Medicine, online March
25, 2019.
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |